Novonesis A/S

CPSE:NSIS B Stock Report

Market Cap: DKK 188.1b

Novonesis Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Ester Baiget

Chief executive officer

€3.9m

Total compensation

CEO salary percentage33.3%
CEO tenure4.8yrs
CEO ownershipn/a
Management average tenure3.7yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Ester Baiget's remuneration changed compared to Novonesis's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

€283m

Mar 31 2024n/an/a

€332m

Dec 31 2023€4m€1m

€406m

Sep 30 2023n/an/a

€430m

Jun 30 2023n/an/a

€460m

Mar 31 2023n/an/a

€487m

Dec 31 2022€3m€1m

€494m

Sep 30 2022n/an/a

€460m

Jun 30 2022n/an/a

€418m

Mar 31 2022n/an/a

€416m

Dec 31 2021€3m€1m

€423m

Sep 30 2021n/an/a

€427m

Jun 30 2021n/an/a

€409m

Mar 31 2021n/an/a

€389m

Dec 31 2020€3m€927k

€380m

Compensation vs Market: Ester's total compensation ($USD4.06M) is about average for companies of similar size in the Danish market ($USD3.64M).

Compensation vs Earnings: Ester's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Ester Baiget (53 yo)

4.8yrs

Tenure

€3,903,958

Compensation

Ms. Ester Baiget serves as Chief Executive Officer and President of Novozymes A/S since joining on February 1, 2020. She serves as Member of Supervisory Board at Akzo Nobel N.V. since 2022. She served as t...

Leadership Team

NamePositionTenureCompensationOwnership
Ester Baiget
President & CEO4.8yrs€3.90mno data
Rainer Lehmann
Executive VP & CFO1.1yrs€858.60kno data
Anders Lund
Chief Operating Officerless than a year€1.03mno data
Claus Fuglsang
Chief Scientific Officer4.3yrsno datano data
Tobias Bjorklund
Head of Investor Relationsno datano datano data
Tue Micheelsen
Vice President of Global Sales & Marketingno datano datano data
Morten Rasmussen
Executive Vice President of People & Stakeholder Relations3.7yrsno datano data
Tina Fano
Executive Vice President of Planetary Health Biosolutions8.8yrs€1.02mno data
Amy Byrick
Executive Vice President of Human Health Biosolutions3.7yrsno datano data
Henrik Nielsen
Executive Vice President of Strategy & Integrationless than a yearno datano data
Jacob Paulsen
Executive Vice President of Food & Beverage Biosolutionsless than a yearno datano data
Peter Rosholm
Chief Executive Officer of Albumedix8.9yrsno datano data

3.7yrs

Average Tenure

50yo

Average Age

Experienced Management: NSIS B's management team is considered experienced (3.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jesper Brandgaard
Vice Chair of the Boardless than a yearno datano data
Cornelis de Jong
Independent Chairman4.8yrs€239.07k0.0011%
DKK 2.0m
Kim Stratton
Independent Director7.8yrs€173.33kno data
Kasim Kutay
Director7.8yrs€107.73k0.00023%
DKK 432.6k
Heine Dalsgaard
Director4.8yrs€143.55k0.00065%
DKK 1.2m
Lise Kaae
Directorless than a yearno datano data
Lena Holskov
Employee Representative Director11.8yrs€66.91kno data
Anders Knudsen
Employee Representative Director11.8yrs€71.77kno data
Sharon James
Independent Director4.8yrs€143.55kno data
Preben Nielsen
Employee Representative Director3.8yrs€107.73k0.000090%
DKK 169.3k
Jens Obro
Employee Representative Director3.8yrs€71.77k0.00012%
DKK 225.7k
Morten Otto Sommer
Independent Director2.8yrs€137.51k0.00022%
DKK 413.8k

4.8yrs

Average Tenure

58.5yo

Average Age

Experienced Board: NSIS B's board of directors are considered experienced (4.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 14:57
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Novonesis A/S is covered by 40 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael Vitfell-RasmussenABG Sundal Collier
Jyoti PrakashAlphaValue
Carla BänzigerBank Vontobel AG